Concurrently, the level of its target, miR-145-5p, was significantly decreased, resulting in enhanced cell proliferation and increased secretion of IL‐1β and IL‐6 in RA cells (Table S1) [41]. The gene discussed is IL6; the disease is rheumatoid arthritis.